Fingerprint
Dive into the research topics of 'Afatinib: Emerging next-generation tyrosine kinase inhibitor for NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Afatinib: Emerging next-generation tyrosine kinase inhibitor for NSCLC
Valerie Nelson, Jacqueline Ziehr, Mark Agulnik, Melissa Johnson*
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
79
Scopus
citations